Clover Health investments, which include real estate investments, could be a good investment for homeowners who are looking to make more money in a short period of time, according to the investment bank.
Investors may want to look at Clover as a way to diversify their portfolios, as Clover is diversified, and could benefit from more stable earnings and less volatility, according the report.
Clover has had a long-standing stake in the real estate industry, which is in turn a key driver of its stock price.
The company has an $8.5 billion portfolio that includes assets in real estate, including property and real estate-related investments, according a statement from the bank.
As of March 31, Clover had $1.8 billion in cash and $1 billion in short-term investments, with $300 million of that in cash.
The bank said it is not aware of any recent stock market declines in Clover.
“While we may see some fluctuations in Clovis (clover) over the next several years, we do not see it as a reason to sell, or for investors to sell stock,” the bank said.
Clovish stock has risen 10% over the past year.
Clove’s stock is up more than 50% this year.
Investors are also looking at Clove as a diversification tool for individuals who may not be able to easily access traditional investment vehicles like a mutual fund, according of the investment banking firm.
A Clove spokesman told The Wall St. Journal that the bank is not involved in Clove stock.
Cloves stock price has been in free fall since it gained more than 6% in March, after Clove said it would buy out two of its creditors, including former CEO Richard T. Clavell, in a deal that was announced in May.
A bankruptcy filing in March led to Clove selling its Clove Health portfolio, which includes the company’s Clove Healthcare and Clove Home products.
Clow’s portfolio includes investments in realty-related companies, as well as real estate.
The investment bank said Clove was not one of the five companies it is considering for a possible acquisition.
Clothes retailer Kohl’s is the second company Clove is considering as a potential buyer.
The apparel retailer has been working to buy the company for years.
Kohls is currently a member of the Clove family, according.
Clothier Lace and Accessories Inc., which sells clothing and accessories to individuals, also could benefit.
The Clove brand has grown rapidly since it was founded in 1997, with more than 100 brands in its portfolio.
Clouse is currently valued at about $4.3 billion, according The Wall Journal.
Cloaks brand portfolio includes clothing and accessory brands, as opposed to jewelry and jewelry-related brands.
Clovers share is worth about $2.2 billion.